Steve Damment
Fondateur chez Aluztura Bio Ltd.
Provenance du réseau au premier degré de Steve Damment
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
95
| Public Company | Pharmaceuticals: Major | 95 |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986
37
| Extinct | Miscellaneous Commercial Services | 37 |
| Public Company | Pharmaceuticals: Major | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Steve Damment via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| SHIRE | Pharmaceuticals: Major | Chief Administrative Officer Chairman Director/Board Member Director/Board Member General Counsel Corporate Officer/Principal Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member Chairman Director of Finance/CFO Director/Board Member Director/Board Member | |
| University of Bristol | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal President Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | President Corporate Officer/Principal President Private Equity Investor | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman | |
| University of London | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| DECHRA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Chairman | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer | |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Imperial College London | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Bath | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| PASSAGE BIO, INC. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer General Counsel | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Founder Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Corporate Officer/Principal | |
Morphotek, Inc.
 Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ELICIO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | General Counsel Chief Operating Officer | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| North Carolina State University | College/University | Undergraduate Degree Undergraduate Degree | |
Sapience Therapeutics, Inc.
 Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The private company is based in Cambridge, MA. | Miscellaneous Commercial Services | President Chief Tech/Sci/R&D Officer | |
| The University of Exeter | College/University | Graduate Degree Doctorate Degree | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Bayes Business School | College/University | Masters Business Admin Masters Business Admin | |
| Georgetown University | College/University | Undergraduate Degree Graduate Degree | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
| Arizona State University | College/University | Director/Board Member Undergraduate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing |
Statistiques
Internationale
| Etats-Unis | 33 |
| Royaume-Uni | 16 |
| Canada | 2 |
| Irlande | 2 |
| Suisse | 2 |
Sectorielle
| Health Technology | 33 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 490 |
| Corporate Officer/Principal | 278 |
| Independent Dir/Board Member | 136 |
| Chairman | 133 |
| Chief Executive Officer | 83 |
Relations les plus connectées
| Insiders | |
|---|---|
| Argeris Karabelas | 42 |
| Tamar Howson | 41 |
| Charlie Sanders | 38 |
| Christopher Viehbacher | 37 |
| Richard Sykes | 37 |
| Elaine Jones | 37 |
| David Lawrence | 29 |
| Tim Tyson | 28 |
| Howard H. Pien | 27 |
| Faheem Hasnain | 27 |
| James Phillips | 24 |
| Robert Ruffolo | 24 |
| Maxine Gowen | 23 |
| Patrick J. Langlois | 23 |
| Eliseo Salinas | 22 |
- Bourse
- Insiders
- Steve Damment
- Connexions Sociétés
